Holte H - Search Results

1

Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis.

Leppä S, Jørgensen J, Tierens A, Meriranta L, Østlie I, de Nully Brown P, Fagerli UM, Larsen TS, Mannisto S, Munksgaard L, Maisenhölder M, Vasala K, Meyer P, Jerkeman M, Björkholm M, Fluge Ø, Jyrkkiö S, Liestøl K, Ralfkiaer E, Spetalen S, Beiske K, Karjalainen-Lindsberg ML, Holte H. Leppä S, et al. Among authors: holte h. Blood Adv. 2020 May 12;4(9):1906-1915. doi: 10.1182/bloodadvances.2020001518. Blood Adv. 2020. PMID: 32380536 Free PMC article. Clinical Trial.

2

T-cell receptor tau delta +/CD3+4-8-T- cell acute lymphoblastic leukemias: a distinct subgroup of leukemias in children. A report of five cases.

Alfsen GC, Beiske K, Holte H, Hovig E, Deggerdal A, Sandlie I, Widing E, Slørdahl S, Klepper LK, Sizoo W, et al. Alfsen GC, et al. Among authors: holte h. Blood. 1991 May 1;77(9):2023-30. Blood. 1991. PMID: 1826854 Free article.

3

Intracellular events associated with inhibition of B cell activation by monoclonal antibodies to HLA class II antigens.

Holte H, Blomhoff HK, Beiske K, Funderud S, Torjesen P, Gaudernack G, Stokke T, Smeland EB. Holte H, et al. Eur J Immunol. 1989 Jul;19(7):1221-5. doi: 10.1002/eji.1830190711. Eur J Immunol. 1989. PMID: 2547623

4

Ki67 and 4F2 antigen expression as well as DNA synthesis predict survival at relapse/tumour progression in low-grade B-cell lymphoma.

Holte H, de Lange Davies C, Beiske K, Stokke T, Marton PF, Smeland EB, Høie J, Kvaløy S. Holte H, et al. Int J Cancer. 1989 Dec 15;44(6):975-80. doi: 10.1002/ijc.2910440605. Int J Cancer. 1989. PMID: 2606582

5

Purging of tumor cells from leukapheresis products: experimental and clinical aspects.

Kvalheim G, Wang MY, Pharo A, Holte H, Jacobsen E, Beiske K, Kvaløy S, Smeland E, Funderud S, Fodstad O. Kvalheim G, et al. Among authors: holte h. J Hematother. 1996 Aug;5(4):427-36. doi: 10.1089/scd.1.1996.5.427. J Hematother. 1996. PMID: 8877718 Review.

6

High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin's lymphoma.

Blystad A, Kvalheim G, Torlakovic E, Holte H, Jacobsen E, Beiske K, Vâlerhaugen H, Lenschow E, Kvaloy S. Blystad A, et al. Among authors: holte h. Bone Marrow Transplant. 1999 Oct;24(8):865-72. doi: 10.1038/sj.bmt.1701990. Bone Marrow Transplant. 1999. PMID: 10516698

7

High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas.

Blystad AK, Enblad G, Kvaløy S, Berglund A, Delabie J, Holte H, Carlson K, Kvalheim G, Bengtsson M, Hagberg H. Blystad AK, et al. Among authors: holte h. Bone Marrow Transplant. 2001 Apr;27(7):711-6. doi: 10.1038/sj.bmt.1702867. Bone Marrow Transplant. 2001. PMID: 11360110

8

CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial.

Osby E, Hagberg H, Kvaløy S, Teerenhovi L, Anderson H, Cavallin-Stahl E, Holte H, Myhre J, Pertovaara H, Björkholm M; Nordic Lymphoma Group. Osby E, et al. Among authors: holte h. Blood. 2003 May 15;101(10):3840-8. doi: 10.1182/blood-2002-10-3238. Epub 2003 Jan 16. Blood. 2003. PMID: 12531794 Free article. Clinical Trial.

9

ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma--the Nordic Lymphoma Group experience.

Jerkeman M, Leppä S, Kvaløy S, Holte H. Jerkeman M, et al. Among authors: holte h. Eur J Haematol. 2004 Sep;73(3):179-82. doi: 10.1111/j.1600-0609.2004.00294.x. Eur J Haematol. 2004. PMID: 15287915 Clinical Trial.

10

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction.

Bea S, Zettl A, Wright G, Salaverria I, Jehn P, Moreno V, Burek C, Ott G, Puig X, Yang L, Lopez-Guillermo A, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Gascoyne RD, Connors JM, Grogan TM, Braziel R, Fisher RI, Smeland EB, Kvaloy S, Holte H, Delabie J, Simon R, Powell J, Wilson WH, Jaffe ES, Montserrat E, Muller-Hermelink HK, Staudt LM, Campo E, Rosenwald A; Lymphoma/Leukemia Molecular Profiling Project. Bea S, et al. Among authors: holte h. Blood. 2005 Nov 1;106(9):3183-90. doi: 10.1182/blood-2005-04-1399. Epub 2005 Jul 26. Blood. 2005. PMID: 16046532 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

287 results

Search Page